The University of Toronto announces plans to build a new 14-storey Innovation Centre, replacing the western portion of the Banting and Best complex, located at the corner of College Street and University Avenue, with expected completion in 2021.

Swift Medical CEO Carlo Perez was recognized as one of the finalists for EY Entrepreneur of the Year 2018. The awards recognize entrepreneurial spirit and purpose-driven leadership for the future of the healthcare industry.

Canadian Technology Accelerator (CTA) for Health IT in Philadelphia is a three-month mentoring and orientation program for small and medium-sized digital health enterprises, with a five-day orientation in Philadelphia with key members of the city's healthcare community.

A new round of Genome Canada’s Genomic Applications Partnership Program (GAPP) funding is now available for research collaborations on developing genomics-derived technologies.

Canadian Technology Accelerator (CTA) San Francisco – Life Sciences is an intensive program run by the Trade Commissioner Service (TCS) team in San Francisco. It offers Canadian companies the opportunity to expand their business in a global hub for the life sciences sector. The program is accepting applications for the winter 2018 cohort, which will run November 2018 – February 2019.

Biotechnology Focus magazine is conducting a survey to gauge Canada’s innovation culture. In support of Global Biotech Week (Sept 24-30), add your voice to the Innovation Report by taking this quick survey by July 27th.

VentureLAB brings you a collaborative workshop offering real-world, practical tools, frameworks and tips for commercializing digital healthcare solutions in the U.S. market.

KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.

JLABS Meet with.. Series helps build partnerships with Amgen and AmorChem. Amgen is seeking for opportunities in relation to their capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, discovery research and technology. AmorChem involves financing research-stage projects for them to reach pre-clinical proof-of-concept in a semi-virtual mode. 

Toronto’s Antibe Therapeutics released positive secondary endpoint data, conducted in their 244 patients, from the recent Phase 2B Gastrointestinal safety study for its lead drug, ATB-346. These results are consistent with the primary endpoint data, previously released on March 20, 2018.

The Government of Canada has announced Stream 4 of the Strategic Innovation Fund and that Statements of Interest will be accepted until August 31, 2018. 

Ontario's Ministry of International Trade is organizing a Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018, Pennsylvania Convention Center. This Trade Mission will be able to accommodate a maximum of eight Ontario companies.

Ontario companies with capabilities in rehabilitation or assistive technology and device that can help China better take care of its disabled and aging population are warmly invited to B2B meetings, site visits and briefing, seminars/forum, and exhibitions of the Canada Pavilion at the 2018 China International Care & Rehabilitation Expo (CRE) in Beijing. 

Perimeter is pleased to announce the appointment of Charles S. Carignan as the New CEO, who has an extensive experience in developing and commercializing innovative OCT based tissue imaging solutions.

Springboard is recruiting women-led digital health companies to join their 2018 Health Innovation Hub cohort to help those seeking growth funding accelerate through an inflection point of growth. 

CellAegis completed its patient enrollment in a large-scale, UK investigator-sponsored trial to further assess the efficacy of remote ischemic conditioning in reducing clinical events in patients presenting with STEMI in patients receiving treatment in hospital catheterization labs or emergency rooms.

If you missed the Medical Device Playbook hosted by StarFish Medical and OBIO, you can still watch Starfish CEO Scott Phillips' presentation titled "Dream a Bigger Dream".